Laxido Paediatric Plain, 6.9 g sachet, powder for oral solution.

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 04/09/20

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 4/9/2020

Click on this link to Download PDF directly

Galen Pharma Ireland Limited

Galen Limited

Company Products

Medicine NameActive Ingredients
Medicine Name Erdotin 300mg Capsules Active Ingredients Erdosteine
Medicine Name Kapake 15mg/500mg Tablets Active Ingredients Codeine Phosphate Hemihydrate, Paracetamol
Medicine Name Kapake 30mg/500mg Tablets Active Ingredients Codeine Phosphate, Paracetamol DC
Medicine Name Laxido Orange, powder for oral solution Active Ingredients Macrogol 3350, Potassium Chloride, Sodium Chloride, Sodium Hydrogen Carbonate
Medicine Name Laxido Paediatric Plain, 6.9 g sachet, powder for oral solution. Active Ingredients Macrogol 3350, Potassium Chloride, Sodium Chloride, Sodium Hydrogen Carbonate
Medicine Name PENTHROX 3mL inhalation vapour, liquid Active Ingredients Methoxyflurane
Medicine Name THORENS 10 000 I.U. /ml oral drops, solution Active Ingredients Colecalciferol (Vitamin D3)
Medicine Name THORENS 25 000 I.U. /2.5 ml oral solution Active Ingredients Colecalciferol (Vitamin D3)
Medicine Name Tramake 100mg Tablets Active Ingredients Tramadol Hydrochloride
Medicine Name Tramake 50mg Tablets Active Ingredients Tramadol Hydrochloride
1 - 0 of 10 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 4 September 2020 PIL

Reasons for updating

  • Change to section 2 - excipient warnings
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 4 September 2020

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Updated on 21 November 2019

Reasons for updating

  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text

Updated on 25 April 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 25 April 2019

Reasons for updating

  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Updated on 7 March 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 27 February 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 14 February 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision
  • Addition of manufacturer

Updated on 17 August 2018

Reasons for updating

  • File format updated to PDF

Updated on 3 November 2017

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 3 November 2017 SPC

Reasons for updating

  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

.

Updated on 1 November 2017 PIL

Reasons for updating

  • New PIL for new product

Updated on 1 November 2017 PIL

Reasons for updating

  • Change to section 6 - date of revision
  • Change to section 6 - what the product contains
  • Change to Section 1 - what the product is
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 3 - how to take/use
  • Change to section 3 - duration of treatment
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store or dispose

Updated on 24 November 2016 PIL

Reasons for updating

  • Change to section 6 - date of revision

Updated on 2 September 2015 SPC

Reasons for updating

  • New SPC for new product

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

None provided

Updated on 1 September 2015 PIL

Reasons for updating

  • New PIL for new product